These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11161282)

  • 21. Chimeric HIV-1 and HIV-2 lentiviral vectors with added safety insurance.
    Sachdeva G; D'Costa J; Cho JE; Kachapati K; Choudhry V; Arya SK
    J Med Virol; 2007 Feb; 79(2):118-26. PubMed ID: 17177309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.
    Srinivasakumar N; Schuening FG
    J Virol; 1999 Nov; 73(11):9589-98. PubMed ID: 10516068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination.
    Nikolaitchik O; Rhodes TD; Ott D; Hu WS
    J Virol; 2006 May; 80(10):4691-7. PubMed ID: 16641262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity.
    Griffin SD; Allen JF; Lever AM
    J Virol; 2001 Dec; 75(24):12058-69. PubMed ID: 11711596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation.
    McBride MS; Schwartz MD; Panganiban AT
    J Virol; 1997 Jun; 71(6):4544-54. PubMed ID: 9151848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage.
    Strappe PM; Hampton DW; Brown D; Cachon-Gonzalez B; Caldwell M; Fawcett JW; Lever AM
    Retrovirology; 2005 Sep; 2():55. PubMed ID: 16168051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of gag and RRE Sequences on HIV-1 RNA Packaging Signal Structure and Function.
    Kharytonchyk S; Brown JD; Stilger K; Yasin S; Iyer AS; Collins J; Summers MF; Telesnitsky A
    J Mol Biol; 2018 Jul; 430(14):2066-2079. PubMed ID: 29787767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lentiviral vectors for gene therapy of HIV-1 infection.
    Mautino MR
    Curr Gene Ther; 2002 Feb; 2(1):23-43. PubMed ID: 12108972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved primate foamy virus vectors and packaging constructs.
    Heinkelein M; Dressler M; Jármy G; Rammling M; Imrich H; Thurow J; Lindemann D; Rethwilm A
    J Virol; 2002 Apr; 76(8):3774-83. PubMed ID: 11907217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro.
    Lanchy JM; Szafran QN; Lodmell JS
    Nucleic Acids Res; 2004; 32(15):4585-95. PubMed ID: 15333691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helper plasmids for production of HIV-1-derived vectors.
    Fuller M; Anson DS
    Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region.
    Barksdale SK; Baker CC
    Mol Cell Biol; 1995 Jun; 15(6):2962-71. PubMed ID: 7760794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of a cryptic splice donor in human immunodeficiency virus type-1.
    Borg KT; Favaro JP; Arrigo SJ; Schmidt M
    J Biomed Sci; 1999 Jan; 6(1):45-52. PubMed ID: 9933742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element.
    Mautino MR; Keiser N; Morgan RA
    Gene Ther; 2000 Aug; 7(16):1421-4. PubMed ID: 10981670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An extended stem-loop 1 is necessary for human immunodeficiency virus type 2 replication and affects genomic RNA encapsidation.
    Lanchy JM; Lodmell JS
    J Virol; 2007 Apr; 81(7):3285-92. PubMed ID: 17229705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.
    Srinivasakumar N; Chazal N; Helga-Maria C; Prasad S; Hammarskjöld ML; Rekosh D
    J Virol; 1997 Aug; 71(8):5841-8. PubMed ID: 9223473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.